Valsartan Settlement Masters Appointed To Advance Negotiations in MDL
The U.S. District Judge presiding over all valsartan lawsuits filed throughout the federal court system has appointed two former judges as settlement counsel, in order to advance negotiations in the ongoing litigation over contaminated versions of the generic blood pressure pills that have been linked to hundreds of reports of cancer.
Following changes to the generic drug manufacturing process, a series of valsartan recalls have been issued since late 2018, after it was discovered that pills distributed throughout the U.S. in prior years were contaminated with high levels of N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA) and other chemical byproducts known to increase the risk of stomach cancer, liver cancer, esophageal cancer, prostate cancer, pancreatic cancer, and other injuries.
There are already more than 1,000 product liability lawsuits pending nationwide against manufacturers and distributors of the contaminated valsartan pills, and the parties are preparing a small group of representative cases for early “bellwether” trials, which are designed to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout hundreds of claims.
Given common questions of fact and law raised in complaints filed in U.S. District Courts nationwide, the federal litigation has been centralized for pretrial proceedings before U.S. District Judge Robert B. Kugler in the District of New Jersey, as part of a multidistrict litigation (MDL), where the parties have been engaging in common discovery that applies to all claims.
In a case management order (PDF) issued on March 3, Judge Kugler appointed retired U.S. District Judges Gregory M. Sleet and Lawrence F. Stengel as settlement special masters, whose job it will be to conduct advanced settlement negotiations in an effort to resolve the litigation without the need for hundreds of cases to go to trial.
The special masters were nominated by both parties, and have the authority to formally appoint valsartan settlement counsel to represent each party.
If the parties fail to make progress toward a resolution for the litigation or valsartan cancer settlements program, it is expected that Judge Kugler will move forward with a series of “bellwether” trials, and then consider remanding large numbers of claims back to U.S. District Courts nationwide for separate trial dates in the future.
LyndaJuly 23, 2022 at 3:16 pm
I took the recalled Valsartan. I was notified by my pharmacy to discontinue use because my pills were a part of the recalled batch. (2018) Fast forward to 2022. I have now been diagnosed with two separate melanomas. I have had surgery on the first one, May, 2022. The second surgery is scheduled for August, 2022. How does one prove or disprove that they are related?
DavidJune 4, 2022 at 8:33 pm
I have been taking Losartan PTSM 100 MG , for many years . I remember when this recall happened . I asked my pharmacist about it and he said I was not taking that certain brand . I was diagnosed with stage 3 colon cancer in an January 2020 , at Duke University Hospital . I had a colonoscopy in 2016 but I believe my doctor missed a polyp in my cecum . My tumor was tested and was from an outside so[Show More]I have been taking Losartan PTSM 100 MG , for many years . I remember when this recall happened . I asked my pharmacist about it and he said I was not taking that certain brand . I was diagnosed with stage 3 colon cancer in an January 2020 , at Duke University Hospital . I had a colonoscopy in 2016 but I believe my doctor missed a polyp in my cecum . My tumor was tested and was from an outside source . I have always wondered if the Losartan might have caused my cancer .
BerniceApril 25, 2022 at 11:33 pm
I knew all along that Lasartan was my problem. I was hospitalized six times because of that crap. The St Cloud said we don't know what caused this. It took 10 months for my lungs to clear out and after that I got cancer. I feel very angry for the way it ruined the rest of my life . This is my third letter.
"*" indicates required fields
More Top Stories
Thousands of Camp Lejeune water contamination lawsuits are likely to be filed ahead of a February 6 filing deadline.
The Dark & Lovely uterine cancer lawsuit blames the presence of toxic chemicals in hair relaxer for the cancer diagnosis.
A new district judge has been put in charge of federal talcum powder litigation following the retirement of U.S. District Judge Freda Wolfson, who has been overseeing pretrial proceedings for the litigation.